Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions

Autores
Liu, Grace; Segrè, Joel; Gülmezoglu, A Metin; Mathai, Matthews; Smith, Jeffrey M; Hermida, Jorge; Simen Kapeu, Aline; Barker, Pierre; Jere, Mercy; Moses, Edward; Moxon, Sarah G.; Dickson, Kim E.; Lawn, Joy E.; Althabe, Fernando
Año de publicación
2015
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
BACKGROUND:Preterm birth complications are the leading cause of deaths for children under five years. Antenatal corticosteroids (ACS) are effective at reducing mortality and serious morbidity amongst infants born at <34 weeks gestation. WHO guidelines strongly recommend use of ACS for women at risk of imminent preterm birth where gestational age, imminent preterm birth, and risk of maternal infection can be assessed, and appropriate maternal/newborn care provided. However, coverage remains low in high-burden countries for reasons not previously systematically investigated.METHODS:The bottleneck analysis tool was applied in 12 countries in Africa and Asia as part of the Every Newborn Action Plan process. Country workshops involved technical experts to complete the survey tool, which is designed to synthesise and grade health system "bottlenecks", factors that hinder the scale up, of maternal-newborn intervention packages. We used quantitative and qualitative methods to analyse the bottleneck data, combined with literature review, to present priority bottlenecks and actions relevant to different health system building blocks for ACS.RESULTS:Eleven out of twelve countries provided data in response to the ACS questionnaire. Health system building blocks most frequently reported as having significant or very major bottlenecks were health information systems (11 countries), essential medical products and technologies (9 out of 11 countries) and health service delivery (9 out of 11 countries). Bottlenecks included absence of coverage data, poor gestational age metrics, lack of national essential medicines listing, discrepancies between prescribing authority and provider cadres managing care, delays due to referral, and lack of supervision, mentoring and quality improvement systems.CONCLUSIONS:Analysis centred on health system building blocks in which 9 or more countries (>75%) reported very major or significant bottlenecks. Health information systems should include improved gestational age assessment and track ACS coverage, use and outcomes. Better health service delivery requires clarified policy assigning roles by level of care and cadre of provider, dependent on capability to assess gestational age and risk of preterm birth, and the implementation of guidelines with adequate supervision, mentoring and quality improvement systems, including audit and feedback. National essential medicines lists should include dexamethasone for antenatal use, and dexamethasone should be integrated into supply logistics.
Fil: Liu, Grace. United Nations Commodities Commission. Antenatal Corticosteroids Working Group; Estados Unidos
Fil: Segrè, Joel. United Nations Commodities Commission. Antenatal Corticosteroids Working Group; Estados Unidos
Fil: Gülmezoglu, A Metin. World Health Organization. Special Programme of Research, Development and Research Training in Human Reproduction ; Suiza
Fil: Mathai, Matthews. Health Organization. Department of Maternal, Newborn, Child & Adolescent Health; Suiza
Fil: Smith, Jeffrey M. Jhpiego; Estados Unidos
Fil: Hermida, Jorge. University Research Co.; Estados Unidos
Fil: Simen Kapeu, Aline. Organización de Las Naciones Unidas. Unicef; Argentina
Fil: Barker, Pierre. Institute for Healthcare Improvement; Estados Unidos
Fil: Jere, Mercy. MaiKhanda Trust; Malaui
Fil: Moses, Edward. MaiKhanda Trust; Malaui
Fil: Moxon, Sarah G.. Maternal, Adolescent, Reproductive and Child Health Centre; Reino Unido
Fil: Dickson, Kim E.. Organización de Las Naciones Unidas. Unicef; Argentina
Fil: Lawn, Joy E.. Maternal, Adolescent, Reproductive and Child Health Centre; Reino Unido
Fil: Althabe, Fernando. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Materia
Antenatal corticosteroids
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/47397

id CONICETDig_bbd6ba9d08633ee0feb9cb967bee0801
oai_identifier_str oai:ri.conicet.gov.ar:11336/47397
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutionsLiu, GraceSegrè, JoelGülmezoglu, A MetinMathai, MatthewsSmith, Jeffrey MHermida, JorgeSimen Kapeu, AlineBarker, PierreJere, MercyMoses, EdwardMoxon, Sarah G.Dickson, Kim E.Lawn, Joy E.Althabe, FernandoAntenatal corticosteroidshttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3BACKGROUND:Preterm birth complications are the leading cause of deaths for children under five years. Antenatal corticosteroids (ACS) are effective at reducing mortality and serious morbidity amongst infants born at <34 weeks gestation. WHO guidelines strongly recommend use of ACS for women at risk of imminent preterm birth where gestational age, imminent preterm birth, and risk of maternal infection can be assessed, and appropriate maternal/newborn care provided. However, coverage remains low in high-burden countries for reasons not previously systematically investigated.METHODS:The bottleneck analysis tool was applied in 12 countries in Africa and Asia as part of the Every Newborn Action Plan process. Country workshops involved technical experts to complete the survey tool, which is designed to synthesise and grade health system "bottlenecks", factors that hinder the scale up, of maternal-newborn intervention packages. We used quantitative and qualitative methods to analyse the bottleneck data, combined with literature review, to present priority bottlenecks and actions relevant to different health system building blocks for ACS.RESULTS:Eleven out of twelve countries provided data in response to the ACS questionnaire. Health system building blocks most frequently reported as having significant or very major bottlenecks were health information systems (11 countries), essential medical products and technologies (9 out of 11 countries) and health service delivery (9 out of 11 countries). Bottlenecks included absence of coverage data, poor gestational age metrics, lack of national essential medicines listing, discrepancies between prescribing authority and provider cadres managing care, delays due to referral, and lack of supervision, mentoring and quality improvement systems.CONCLUSIONS:Analysis centred on health system building blocks in which 9 or more countries (>75%) reported very major or significant bottlenecks. Health information systems should include improved gestational age assessment and track ACS coverage, use and outcomes. Better health service delivery requires clarified policy assigning roles by level of care and cadre of provider, dependent on capability to assess gestational age and risk of preterm birth, and the implementation of guidelines with adequate supervision, mentoring and quality improvement systems, including audit and feedback. National essential medicines lists should include dexamethasone for antenatal use, and dexamethasone should be integrated into supply logistics.Fil: Liu, Grace. United Nations Commodities Commission. Antenatal Corticosteroids Working Group; Estados UnidosFil: Segrè, Joel. United Nations Commodities Commission. Antenatal Corticosteroids Working Group; Estados UnidosFil: Gülmezoglu, A Metin. World Health Organization. Special Programme of Research, Development and Research Training in Human Reproduction ; SuizaFil: Mathai, Matthews. Health Organization. Department of Maternal, Newborn, Child & Adolescent Health; SuizaFil: Smith, Jeffrey M. Jhpiego; Estados UnidosFil: Hermida, Jorge. University Research Co.; Estados UnidosFil: Simen Kapeu, Aline. Organización de Las Naciones Unidas. Unicef; ArgentinaFil: Barker, Pierre. Institute for Healthcare Improvement; Estados UnidosFil: Jere, Mercy. MaiKhanda Trust; MalauiFil: Moses, Edward. MaiKhanda Trust; MalauiFil: Moxon, Sarah G.. Maternal, Adolescent, Reproductive and Child Health Centre; Reino UnidoFil: Dickson, Kim E.. Organización de Las Naciones Unidas. Unicef; ArgentinaFil: Lawn, Joy E.. Maternal, Adolescent, Reproductive and Child Health Centre; Reino UnidoFil: Althabe, Fernando. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaBioMed Central2015-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfhttp://hdl.handle.net/11336/47397Liu, Grace; Segrè, Joel; Gülmezoglu, A Metin; Mathai, Matthews; Smith, Jeffrey M; et al.; Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions; BioMed Central; BMC Pregnancy and Childbirth; 15; S2; 9-2015; 1-161741-7015CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1186/1471-2393-15-S2-S3info:eu-repo/semantics/altIdentifier/url/https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/1471-2393-15-S2-S3info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T14:47:55Zoai:ri.conicet.gov.ar:11336/47397instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 14:47:55.428CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions
title Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions
spellingShingle Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions
Liu, Grace
Antenatal corticosteroids
title_short Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions
title_full Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions
title_fullStr Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions
title_full_unstemmed Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions
title_sort Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions
dc.creator.none.fl_str_mv Liu, Grace
Segrè, Joel
Gülmezoglu, A Metin
Mathai, Matthews
Smith, Jeffrey M
Hermida, Jorge
Simen Kapeu, Aline
Barker, Pierre
Jere, Mercy
Moses, Edward
Moxon, Sarah G.
Dickson, Kim E.
Lawn, Joy E.
Althabe, Fernando
author Liu, Grace
author_facet Liu, Grace
Segrè, Joel
Gülmezoglu, A Metin
Mathai, Matthews
Smith, Jeffrey M
Hermida, Jorge
Simen Kapeu, Aline
Barker, Pierre
Jere, Mercy
Moses, Edward
Moxon, Sarah G.
Dickson, Kim E.
Lawn, Joy E.
Althabe, Fernando
author_role author
author2 Segrè, Joel
Gülmezoglu, A Metin
Mathai, Matthews
Smith, Jeffrey M
Hermida, Jorge
Simen Kapeu, Aline
Barker, Pierre
Jere, Mercy
Moses, Edward
Moxon, Sarah G.
Dickson, Kim E.
Lawn, Joy E.
Althabe, Fernando
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Antenatal corticosteroids
topic Antenatal corticosteroids
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv BACKGROUND:Preterm birth complications are the leading cause of deaths for children under five years. Antenatal corticosteroids (ACS) are effective at reducing mortality and serious morbidity amongst infants born at <34 weeks gestation. WHO guidelines strongly recommend use of ACS for women at risk of imminent preterm birth where gestational age, imminent preterm birth, and risk of maternal infection can be assessed, and appropriate maternal/newborn care provided. However, coverage remains low in high-burden countries for reasons not previously systematically investigated.METHODS:The bottleneck analysis tool was applied in 12 countries in Africa and Asia as part of the Every Newborn Action Plan process. Country workshops involved technical experts to complete the survey tool, which is designed to synthesise and grade health system "bottlenecks", factors that hinder the scale up, of maternal-newborn intervention packages. We used quantitative and qualitative methods to analyse the bottleneck data, combined with literature review, to present priority bottlenecks and actions relevant to different health system building blocks for ACS.RESULTS:Eleven out of twelve countries provided data in response to the ACS questionnaire. Health system building blocks most frequently reported as having significant or very major bottlenecks were health information systems (11 countries), essential medical products and technologies (9 out of 11 countries) and health service delivery (9 out of 11 countries). Bottlenecks included absence of coverage data, poor gestational age metrics, lack of national essential medicines listing, discrepancies between prescribing authority and provider cadres managing care, delays due to referral, and lack of supervision, mentoring and quality improvement systems.CONCLUSIONS:Analysis centred on health system building blocks in which 9 or more countries (>75%) reported very major or significant bottlenecks. Health information systems should include improved gestational age assessment and track ACS coverage, use and outcomes. Better health service delivery requires clarified policy assigning roles by level of care and cadre of provider, dependent on capability to assess gestational age and risk of preterm birth, and the implementation of guidelines with adequate supervision, mentoring and quality improvement systems, including audit and feedback. National essential medicines lists should include dexamethasone for antenatal use, and dexamethasone should be integrated into supply logistics.
Fil: Liu, Grace. United Nations Commodities Commission. Antenatal Corticosteroids Working Group; Estados Unidos
Fil: Segrè, Joel. United Nations Commodities Commission. Antenatal Corticosteroids Working Group; Estados Unidos
Fil: Gülmezoglu, A Metin. World Health Organization. Special Programme of Research, Development and Research Training in Human Reproduction ; Suiza
Fil: Mathai, Matthews. Health Organization. Department of Maternal, Newborn, Child & Adolescent Health; Suiza
Fil: Smith, Jeffrey M. Jhpiego; Estados Unidos
Fil: Hermida, Jorge. University Research Co.; Estados Unidos
Fil: Simen Kapeu, Aline. Organización de Las Naciones Unidas. Unicef; Argentina
Fil: Barker, Pierre. Institute for Healthcare Improvement; Estados Unidos
Fil: Jere, Mercy. MaiKhanda Trust; Malaui
Fil: Moses, Edward. MaiKhanda Trust; Malaui
Fil: Moxon, Sarah G.. Maternal, Adolescent, Reproductive and Child Health Centre; Reino Unido
Fil: Dickson, Kim E.. Organización de Las Naciones Unidas. Unicef; Argentina
Fil: Lawn, Joy E.. Maternal, Adolescent, Reproductive and Child Health Centre; Reino Unido
Fil: Althabe, Fernando. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
description BACKGROUND:Preterm birth complications are the leading cause of deaths for children under five years. Antenatal corticosteroids (ACS) are effective at reducing mortality and serious morbidity amongst infants born at <34 weeks gestation. WHO guidelines strongly recommend use of ACS for women at risk of imminent preterm birth where gestational age, imminent preterm birth, and risk of maternal infection can be assessed, and appropriate maternal/newborn care provided. However, coverage remains low in high-burden countries for reasons not previously systematically investigated.METHODS:The bottleneck analysis tool was applied in 12 countries in Africa and Asia as part of the Every Newborn Action Plan process. Country workshops involved technical experts to complete the survey tool, which is designed to synthesise and grade health system "bottlenecks", factors that hinder the scale up, of maternal-newborn intervention packages. We used quantitative and qualitative methods to analyse the bottleneck data, combined with literature review, to present priority bottlenecks and actions relevant to different health system building blocks for ACS.RESULTS:Eleven out of twelve countries provided data in response to the ACS questionnaire. Health system building blocks most frequently reported as having significant or very major bottlenecks were health information systems (11 countries), essential medical products and technologies (9 out of 11 countries) and health service delivery (9 out of 11 countries). Bottlenecks included absence of coverage data, poor gestational age metrics, lack of national essential medicines listing, discrepancies between prescribing authority and provider cadres managing care, delays due to referral, and lack of supervision, mentoring and quality improvement systems.CONCLUSIONS:Analysis centred on health system building blocks in which 9 or more countries (>75%) reported very major or significant bottlenecks. Health information systems should include improved gestational age assessment and track ACS coverage, use and outcomes. Better health service delivery requires clarified policy assigning roles by level of care and cadre of provider, dependent on capability to assess gestational age and risk of preterm birth, and the implementation of guidelines with adequate supervision, mentoring and quality improvement systems, including audit and feedback. National essential medicines lists should include dexamethasone for antenatal use, and dexamethasone should be integrated into supply logistics.
publishDate 2015
dc.date.none.fl_str_mv 2015-09
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/47397
Liu, Grace; Segrè, Joel; Gülmezoglu, A Metin; Mathai, Matthews; Smith, Jeffrey M; et al.; Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions; BioMed Central; BMC Pregnancy and Childbirth; 15; S2; 9-2015; 1-16
1741-7015
CONICET Digital
CONICET
url http://hdl.handle.net/11336/47397
identifier_str_mv Liu, Grace; Segrè, Joel; Gülmezoglu, A Metin; Mathai, Matthews; Smith, Jeffrey M; et al.; Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions; BioMed Central; BMC Pregnancy and Childbirth; 15; S2; 9-2015; 1-16
1741-7015
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1186/1471-2393-15-S2-S3
info:eu-repo/semantics/altIdentifier/url/https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/1471-2393-15-S2-S3
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846082997364719616
score 13.22299